MiNK Therapeutics
Terese Hammond/uclahealth.org

MiNK Therapeutics Welcomes Terese Hammond as New Head of Inflammatory and Pulmonary Diseases

MiNK Therapeutics shared a post on LinkedIn:

“MiNK Therapeutics proudly welcomes Terese C. Hammond, MD as our new Head of Inflammatory and Pulmonary Diseases. A nationally recognized leader in pulmonary and critical care, Dr. Hammond brings decades of experience advancing transformative therapies for patients facing severe immune and respiratory challenges.

She joins MiNK at a pivotal moment as we prepare for:

– A grant-supported clinical trial in GvHD
– A planned pivotal trial in severe pulmonary disease
– Continued expansion of our iNKT platform with real-world insights from the clinic

Her leadership and deep clinical expertise will accelerate our mission to bring next-generation immune reconstitution therapies to patients in critical need.

Read the full announcement.”

MiNK Therapeutics Welcomes Terese Hammond as New Head of Inflammatory and Pulmonary Diseases

More Posts Featuring MiNK Therapeutic.